Medfinder
Expert medication guides

The Found Script

Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.

4035 articles in Drug ShortagesClear all filters
Nitro-Bid shortage update: What patients need to know in 2026
Drug Shortages

Nitro-Bid shortage update: What patients need to know in 2026

Get the latest Nitro-Bid shortage update for 2026. Learn the current status of Nitroglycerin ointment supply and what patients can do now.

By Peter Daggett·
Eylea Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Eylea Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused update on Eylea supply constraints in 2026. Coverage of timeline, prescribing impact, alternatives, and tools.

By Peter Daggett·
Why Is Paxlovid So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Paxlovid So Hard to Find? [Explained for 2026]

Wondering why Paxlovid is so hard to find in 2026? Learn the key reasons behind shortages and what you can do to get your prescription filled fast.

By Peter Daggett·
Xifaxan Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Xifaxan Shortage: What Providers and Prescribers Need to Know in 2026

A clinical briefing on Xifaxan availability in 2026. Covers supply status, prescribing implications, cost barriers, alternatives, and tools for providers.

By Peter Daggett·

37,000+ have already found their meds with Medfinder.

Stop calling pharmacies. Start your search today.

Why Is Amitiza So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Amitiza So Hard to Find? [Explained for 2026]

Struggling to find Amitiza at your pharmacy? Learn why Amitiza (Lubiprostone) is hard to find in 2026 and what you can do to get your prescription filled.

By Peter Daggett·
Trulicity shortage update calendar and availability chart
Drug Shortages

Trulicity Shortage Update: What Patients Need to Know in 2026

Trulicity (dulaglutide) has been in shortage since August 2022. Here's the latest 2026 update on availability, which doses are affected, and what patients should do.

By Peter Daggett·
Empty pharmacy shelf illustrating medication availability challenges
Finding MedicationsDrug Shortages

Why Is Farxiga So Hard to Find? [Explained for 2026]

Struggling to fill your Farxiga prescription? Learn why patients run into trouble finding dapagliflozin, and what you can do about it in 2026.

By Peter Daggett·
Travoprost blog post header image
Finding MedicationsDrug Shortages

Why Is Travoprost So Hard to Find? [Explained for 2026]

Struggling to find travoprost at your pharmacy? Learn why this glaucoma eye drop can be hard to locate and what you can do about it in 2026.

By Peter Daggett·
Empty pharmacy shelf representing Trulicity shortage
Finding MedicationsDrug Shortages

Why Is Trulicity So Hard to Find? [Explained for 2026]

Trulicity (dulaglutide) has been on the FDA shortage list since 2022. Here's exactly why it's hard to find in 2026 and what you can do about it.

By Peter Daggett·
Clobetasol shortage update: What patients need to know in 2026
Drug Shortages

Clobetasol shortage update: What patients need to know in 2026

Get the latest on the Clobetasol shortage in 2026. Learn which formulations are affected, when supply may improve, and what steps to take right now.

By Peter Daggett·
Why Is Onexton So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Onexton So Hard to Find? [Explained for 2026]

Struggling to find Onexton at your pharmacy? Learn why this acne gel is so hard to find in 2026 and what you can do to get your prescription filled.

By Peter Daggett·
Teriparatide Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Teriparatide Shortage: What Providers and Prescribers Need to Know in 2026

A clinical briefing on Teriparatide (Forteo) availability in 2026 for prescribers. Covers supply status, insurance challenges, cost updates, alternatives, and tools to help patients access therapy.

By Peter Daggett·
PreviousPage 67 of 337Next